Orbimed Advisors LLC Invitae Corp Transaction History

Orbimed Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$17.37 - $26.27 $3.86 Million - $5.83 Million	-222,017 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$10.65 - $25.75 $6.42 Million - $15.5 Million	-602,532 Reduced 73.07%	222,017 $5.2 Million
Q4 2018 Feb 14, 2019	SELL	$9.26 - $16.38 $4.17 Million - $7.37 Million	-450,000 Reduced 35.31%	824,549 $9.12 Million
Q3 2018 Nov 14, 2018	SELL	$7.54 - $18.31 $1.84 Million - $4.46 Million	-243,648 Reduced 16.05%	1,274,549 $21.3 Million
Q3 2017 Nov 14, 2017	BUY	$8.89 - $10.4 $13.5 Million - $15.8 Million	1,518,197	1,518,197 $14.2 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.